Connection

ERIC BOERWINKLE to Point Mutation

This is a "connection" page, showing publications ERIC BOERWINKLE has written about Point Mutation.
Connection Strength

0.420
  1. Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations. Nat Commun. 2025 Oct 16; 16(1):9194.
    View in: PubMed
    Score: 0.209
  2. Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder. Pediatr Diabetes. 2014 May; 15(3):252-6.
    View in: PubMed
    Score: 0.091
  3. All for one and one for all: introduction to a coordinated analysis of the Gly-460-Trp alpha-adducin polymorphism. Am J Hypertens. 2000 Jun; 13(6 Pt 1):734-5.
    View in: PubMed
    Score: 0.036
  4. Beta3-adrenergic receptor Trp64Arg polymorphism does not predict incident CHD or carotid intima-media thickness in a community-based sample of whites: the ARIC study. Atherosclerosis Risk in Communities. Hum Genet. 1999 Oct; 105(4):314-9.
    View in: PubMed
    Score: 0.034
  5. The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin Genet. 1998 Jan; 53(1):27-33.
    View in: PubMed
    Score: 0.030
  6. Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics. 2000 Nov; 156(3):1259-75.
    View in: PubMed
    Score: 0.009
  7. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens. 2000 Jul; 18(7):867-76.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.